Nektar Therapeutics reported $27.34M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
ALKERMES ALKS:US 145.05M 15.36M
Amgen AMGN:US $ 1.23B 197M
Astrazeneca AZN:US 3.06B 1.03B
Baxter International BAX:US $ 790M 90M
Biocryst Pharmaceuticals BCRX:US $ 34.28M 1.1M
Biogen BIIB:US $ 634.9M 153M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Cara Therapeutics CARA:US $ 9.32M 2.16M
Dr.Reddys Laboratories DRRD:IN 23.84B 810M
Eisai 4523:JP 110.49B 9.03B
Eli Lilly And LLY:US $ 1.56B 34.1M
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
Exelixis EXEL:US $ 102.86M 3.55M
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Immunogen IMGN:US $ 16.65M 3.07M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Ironwood Pharmaceuticals IRWD:US $ 28.86M 175K
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Macrogenics MGNX:US $ 16.25M 670K
Merk MRK:US $ 2.3B 518M
Mirati Therapeutics MRTX:US $ 53.95M 10.42M
Nektar Therapeutics NKTR:US $ 27.34M 4.8M
Novartis NOVN:VX 3.5B 486M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Takeda 4502:JP 223.43B 7.65B
Teva Pharmaceutical TEVA:IT 819M 39M
Xencor XNCR:US $ 11.27M 102K
YTE INCY:US $ 209.58M 16.62M